| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0008300 | Intron-Exon-Intron | chr7:122076414-122081629 | chr7:122436360-122441575 | 209 nt | 0.4115 |
| hsa_CADPS2_0008400 | Intron-Exon | chr7:122076414-122091503 | chr7:122436360-122451449 | 161 nt | 0.3913 |
| hsa_CADPS2_0008500 | Intron-Exon-Intron | chr7:122076414-122091529 | chr7:122436360-122451475 | 311 nt | 0.4019 |
| hsa_CADPS2_0008600 | Intron-Exon-Intron | chr7:122076414-122102974 | chr7:122436360-122462920 | 209 nt | 0.4115 |
| hsa_CADPS2_0008700 | Intron-Exon | chr7:122076414-122111464 | chr7:122436360-122471410 | 21 nt | 0.5238 |
| hsa_CADPS2_0008800 | Intron-Exon-Intron | chr7:122076414-122111616 | chr7:122436360-122471562 | 85 nt | 0.4353 |
| hsa_CADPS2_0008900 | Intron-Exon | chr7:122076414-122114571 | chr7:122436360-122474517 | 636 nt | 0.4308 |
| hsa_CADPS2_0009000 | Intron-Exon-Intron | chr7:122076414-122131474 | chr7:122436360-122491420 | 151 nt | 0.4172 |
| hsa_CADPS2_0009100 | Intron-Exon-Intron | chr7:122076414-122153369 | chr7:122436360-122513315 | 21 nt | 0.5238 |
| hsa_CADPS2_0009200 | Intron-Exon-Intron | chr7:122076414-122194743 | chr7:122436360-122554689 | 21 nt | 0.5238 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].